Literature DB >> 20501434

Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract.

Jutta Keller1, Christoph Beglinger, Jens Juul Holst, Viola Andresen, Peter Layer.   

Abstract

It is unclear why patients with inflammation of the distal bowel complain of symptoms referable to the upper gastrointestinal tract, specifically to gastric emptying (GE) disturbances. Thus we aimed to determine occurrence and putative pathomechanisms of gastric motor disorders in such patients. Thirteen healthy subjects (CON), 13 patients with Crohn's disease (CD), 10 with ulcerative colitis (UC), and 7 with diverticulitis (DIV) underwent a standardized (13)C-octanoic acid gastric emptying breath test. Plasma glucose, CCK, peptide YY, and glucagon-like peptide-1 (GLP-1) were measured periodically and correlated with GE parameters. Results were given in means +/- SD. Compared with CON, GE half time (T) was prolonged by 50% in CD (115 +/- 55 vs. 182 +/- 95 min, P = 0.037). Six CD, 2 DIV, and 2 UC patients had pathological T (>200 min). Postprandial plasma glucose was increased in all patients but was highest in DIV and correlated with T (r = 0.90, P = 0.006). In CD, mean postprandial CCK levels were increased threefold compared with CON (6.5 +/- 6.7 vs. 2.1 +/- 0.6 pmol/l, P = 0.027) and were correlated with T (r = 0.60, P = 0.041). Compared with CON, GLP-1 levels were increased in UC (25.1 +/- 5.2 vs. 33.5 +/- 13.0 pmol/l, P = 0.046) but markedly decreased in DIV (9.6 +/- 5.2 pmol/l, P < 0.0001). We concluded that a subset of patients with CD, UC, or DIV has delayed GE. GE disturbances are most pronounced in CD and might partly be caused by excessive CCK release. In DIV there might be a pathophysiological link between decreased GLP-1 release, postprandial hyperglycemia, and delayed GE. These explorative data encourage further studies in larger patient groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20501434     DOI: 10.1152/ajpgi.00145.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  16 in total

1.  Azathioprine in the management of enteropathy in cystic fibrosis.

Authors:  Hui-Leng Tan; Neil Shah; Ranjan Suri
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

Review 2.  Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.

Authors:  Hubert Zatorski; Maciej Sałaga; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-29       Impact factor: 3.000

Review 3.  Gastrointestinal motility disorders in inflammatory bowel diseases.

Authors:  Gabrio Bassotti; Elisabetta Antonelli; Vincenzo Villanacci; Marianna Salemme; Manuela Coppola; Vito Annese
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 4.  Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.

Authors:  J J Worthington; F Reimann; F M Gribble
Journal:  Mucosal Immunol       Date:  2017-08-30       Impact factor: 7.313

5.  L-Glutamine and Physical Exercise Prevent Intestinal Inflammation and Oxidative Stress Without Improving Gastric Dysmotility in Rats with Ulcerative Colitis.

Authors:  Raisa de Oliveira Santos; Geovane da Silva Cardoso; Lara da Costa Lima; Mickael Laudrup de Sousa Cavalcante; Mariana Sousa Silva; Ana Karolina Martins Cavalcante; Juliana Soares Severo; Francisca Beatriz de Melo Sousa; Gabriella Pacheco; Even Herlany Pereira Alves; Lívia Maria Soares Nobre; Jand Venes Rolim Medeiros; Roberto Cesar Lima-Junior; Armênio Aguiar Dos Santos; Moisés Tolentino
Journal:  Inflammation       Date:  2020-10-31       Impact factor: 4.092

Review 6.  Role of Incretin Axis in Inflammatory Bowel Disease.

Authors:  Lihua Duan; Xiaoquan Rao; Zachary Braunstein; Amelia C Toomey; Jixin Zhong
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

Review 7.  Visceral Inflammation and Immune Activation Stress the Brain.

Authors:  Peter Holzer; Aitak Farzi; Ahmed M Hassan; Geraldine Zenz; Angela Jačan; Florian Reichmann
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

Review 8.  European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.

Authors:  Jutta Keller; Heinz F Hammer; Paul R Afolabi; Marc Benninga; Osvaldo Borrelli; Enrique Dominguez-Munoz; Dan Dumitrascu; Oliver Goetze; Stephan L Haas; Bruno Hauser; Daniel Pohl; Silvia Salvatore; Marc Sonyi; Nikhil Thapar; Kristin Verbeke; Mark R Fox
Journal:  United European Gastroenterol J       Date:  2021-06-14       Impact factor: 4.623

9.  Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn's disease.

Authors:  Ana Carolina Mello Nóbrega; Bruno Roberto Silva Ferreira; Graciela Josué Oliveira; Kamila Maria Oliveira Sales; Armênio Aguiar Santos; Miguel Ângelo Nobre E Souza; Lúcia Libanês Bessa Campelo Braga; Luiz Ernesto de Almeida Troncon; Marcellus Henrique Loiola Ponte Souza
Journal:  BMC Gastroenterol       Date:  2012-12-07       Impact factor: 3.067

Review 10.  Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1.

Authors:  Tamara Zietek; Eva Rath
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.